The Ministry of Science and Technology Establishes the Research Center for the Development of Next-Generation Artificial Intelligence

Release time:

2025-03-01

On April 26, the Ministry of Science and Technology convened the inaugural meeting of the Research Center for the Development of Next-Generation Artificial Intelligence and a symposium on cutting-edge AI trends. At the invitation of Minister Wang Zhigang, Vice Minister Li Meng attended and chaired the meeting.

The Ministry of Science and Technology Establishes the Research Center for the Development of Next-Generation Artificial Intelligence

On April 26, the Ministry of Science and Technology convened the inaugural meeting of the Research Center for the Development of Next-Generation Artificial Intelligence and a symposium on cutting-edge AI trends. At the invitation of Minister Wang Zhigang, Vice Minister Li Meng attended and chaired the meeting.

　　To strengthen the organizational support and research backing for the implementation of the National New-Generation Artificial Intelligence Development Plan, the Ministry of Science and Technology has established the Research Center for New-Generation Artificial Intelligence Development (hereinafter referred to as the “Research Center”). The Research Center is based at the China Science and Technology Information Institute and the China Academy of Science and Technology Development Strategy, and maintains extensive connections with scholars and industry professionals in the field of artificial intelligence, with the aim of providing advisory recommendations on AI development strategies and cutting-edge technological directions. At the symposium, participating experts—including Zhou Zhihua, Chen Yunji, Wang Xiaogang, Zeng Yi, Zhou Bowen, Shi Yaoyun, Zhang Minling, Yin Shouyi, Cha Zhengjun, and Tang Ke—exchanged views on前沿 trends and development directions in AI, such as machine learning, intelligent chips, computer vision, brain-inspired intelligence, and quantum intelligence.

　　Vice Minister Li Meng stated that the establishment of the research center is a crucial step in advancing China’s artificial intelligence development. He expressed the hope that the center will further strengthen its sense of mission and urgency, enhance long-term, continuous tracking and monitoring, promptly assess major trends, and reinforce its strategic and policy reserves; strive to integrate resources from various think tanks and research institutions to build a widely influential platform for AI research collaboration, thereby pooling efforts to address major AI-related issues in China; and, aligned with strategic objectives and focused on key challenges, conduct sustained research to produce high-quality outcomes, thus making a positive contribution to enabling China to seize the significant opportunities presented by AI development and to drive an overall提升 in national competitiveness.

　　Relevant officials from the relevant departments and units of the Ministry of Science and Technology, as well as researchers from the Research Center for the Development of Next-Generation Artificial Intelligence, attended the meeting.

Related News

Overview of Bioanalytical Methods for Cell Therapy Products

Cell and gene therapy (CGT) can be broadly classified, based on product format, into ex vivo gene therapy and in vivo gene therapy.

2026-04-03

Bioanalytical Strategies for CGT Products: Selected Developments and Validation of qPCR/ddPCR Methodologies

With the rapid development of cell and gene therapy (CGT), dozens of CGT products have now been approved for market launch worldwide.

2026-04-03

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel Structured Market Performance; AI in Healthcare Opens New Growth Opportunities

During the third week of February 2025, the pharmaceutical and biotechnology sector continued to exhibit structural divergence. Over the week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming both the CSI 300 Index and the Shanghai Composite Index, ranking ninth in terms of sector performance.

2025-03-01

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

Recently, the pharmaceutical and biotechnology sector has exhibited a pronounced structural market trend, driven by the deep integration of AI technologies with healthcare applications, which is spurring industry upgrades. At the same time, policy support for innovative drugs continues to strengthen, creating multiple favorable factors for the sector.

2025-03-01

With the concerted support of 17 departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

Recently, the “Policy Measures for Coordinated Support from Relevant Provincial Departments for the Open and Innovative Development of the Biopharmaceutical Industry in the China (Jiangsu) Pilot Free Trade Zone” (hereinafter referred to as the “Policy Measures”) were officially released!

2025-03-01

Medical Device Industry Development Report: Significant Market Potential in Countries Along the Belt and Road

Recently, the “Medical Device Blue Book: Report on the Development of China’s Medical Device Industry (2018),” jointly released in Beijing by the China Association for Pharmaceutical Regulatory Research and the Social Sciences Academic Press, stated that since the Belt and Road Initiative was proposed in 2013, demand for Chinese medical device products has increased among countries along the Belt and Road.

2025-03-01

Share